Financial News
Bicycle Therapeutics Plc ADR (NQ: BCYC )
22.75
-0.35
(-1.52%)
Streaming Delayed Price
Updated: 10:06 AM EDT, Jun 17, 2024
Add to My Watchlist
Headline News about Bicycle Therapeutics Plc ADR
![](https://cdn.benzinga.com/files/images/story/2024/05/23/Image33.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/23/Gold-Yuannotes-China.jpeg?width=1200&height=800&fit=crop)
Gold Falls Sharply; US Composite PMI Surges In May
May 23, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/23/xrdDAFj7f9vwuY2-j5446957451-t23052513.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Expert Ratings For Bicycle Therapeutics
April 10, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Analyst Landscape: 4 Takes On Bicycle Therapeutics
February 21, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics
December 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Bicycle Therapeutics
November 03, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/02/21/walmart_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/15/image48.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Where Bicycle Therapeutics Stands With Analysts
September 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Expert Ratings for Bicycle Therapeutics
August 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/30/la-z-boy_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/747289/research-scientists-drugs-pharma-biotech.jpg)
![](https://g.foolcdn.com/editorial/images/739736/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg)
![](/next-assets/images/schema-image-default.png)
Recap: Bicycle Therapeutics Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Bicycle Therapeutics
April 18, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Looking Into Bicycle Therapeutics's Return On Capital Employed
November 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/13/stratasys_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9478.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/07/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.